Physician

Scott William Harberts, MD

According to 2025 Medicare claims, Scott Harberts, MD (NPI: 1477551521) practices nephrology in the Pueblo, CO market, with the plurality of this provider's patient population coming from Pueblo, CO. This provider's primary affiliated billing organization is SOUTHERN COLORADO NEPHROLOGY ASSOC PC (NPI: 1083642144; TIN: 841121886) and primary practice location at 81004-3878. Harberts is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Harberts' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 267 traditional Medicare patients, billed 3,617 HCPCS/CPT codes, and received $247,190 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,634 prescription claims across 226 beneficiaries totaling $312,152 in drug costs, led by Velphoro (Sucroferric Oxyhydroxide). DME data shows 264 claims. Open Payments data shows 29 records totaling $586. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $186,307 and ending at $312,152. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $966 to $651.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	601	5,054	$235,350
2016	550	2,095	$242,326
2017	560	2,496	$250,562
2018	533	2,392	$229,940
2019	421	1,942	$240,449
2020	427	1,829	$207,479
2021	374	1,590	$201,355
2022	295	1,158	$168,933
2023	289	1,749	$182,711
2024	267	3,617	$247,190

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	236	1,778	$186,307
2016	217	1,697	$233,664
2017	196	1,725	$330,340
2018	193	1,630	$271,642
2019	192	1,496	$248,652
2020	217	1,449	$284,982
2021	225	1,578	$377,950
2022	206	1,478	$328,921
2023	223	1,427	$215,532
2024	226	1,634	$312,152

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	22	328	$40,577
2016	N/R	345	$32,858
2017	24	327	$30,124
2018	12	275	$25,963
2019	N/R	326	$29,876
2020	N/R	310	$20,624
2021	N/R	309	$17,957
2022	N/R	230	$9,231
2023	N/R	276	$6,946
2024	N/R	264	$5,813

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	106	228	$89
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	62	135	$66
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	46	406	$41
99454	Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days	44	386	$41
99458	Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes	44	858	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Velphoro	Sucroferric Oxyhydroxide	30	866	$96,478
Sevelamer Carbonate	Sevelamer Carbonate	110	4,715	$19,818
Farxiga	Dapagliflozin Propanediol	20	930	$16,825
Jardiance	Empagliflozin	27	930	$14,823
Lokelma	Sodium Zirconium Cyclosilicate	17	620	$12,667

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	11	$1,980
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	60	$1,092
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	72	$915
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	37	$647
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	44	$601

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$586	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Scott William Harberts, MD?

Tedicare shows public-source Medicare data for Scott William Harberts, MD (NPI 1477551521), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Scott William Harberts, MD have ACO affiliation data?

Scott William Harberts, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Scott William Harberts, MD?

Scott William Harberts, MD is linked to SOUTHERN COLORADO NEPHROLOGY ASSOC PC (billing NPI 1083642144) in the available physician profile data.

Does Scott William Harberts, MD have Open Payments data?

Scott William Harberts, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.